In consultation with Consulting Editor, Dr. Lucky Jain, Drs. Jonathan M. Davis and Errol R. Norwitz have put together a state-of the-art issue of the Clinics in Perinatology devoted to Perinatal Pharmacology. Clinical review articles are specifically devoted to the following: Drugs for the prevention and treatment of preterm labor; Drugs for the prevention and treatment of hypertensive disorders of pregnancy; Drugs to promote neuroprotection; Medications that cause fetal anomalies and possible prevention strategies; Safety and efficacy of psychotropic medications during pregnancy; Treatment of viral infections during pregnancy (HIV, herpes, CMV, hepatitis C); Drugs to control diabetes during pregnancy; Cardiotonic drugs; Drugs to treat coagulation disorders in the newborn; Drugs for the prevention and treatment of bronchopulmonary dysplasia; Drugs for the prevention and treatment of neonatal brain injury; Drugs for the prevention and treatment of sepsis in the newborn; Analgesia, opioids and other drug use during pregnancy and Neonatal Abstinence Syndrome; Medications and breast feeding; Principles of pharmacokinetics in the pregnant woman and fetus; and Challenges in designing clinical trials to test new drugs in the pregnant woman and fetus. Readers will come away with the latest information on therapeutics as they seek to utilize evidence-based recommendations to improve patient outcomes.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. CME Accreditation Page - p. xi 7. Forthcoming Issues - p. xiii 8. Foreword - p. xv 9. Preface - p. xvii 10. Drugs for the Treatment and Prevention of Preterm Labor - p. 159 11. Treatment and Prevention of Hypertensive Disorders During Pregnancy - p. 173 12. Magnesium Sulfate and Novel Therapies to Promote Neuroprotection - p. 187 13. Medications that Cause Fetal Anomalies and Possible Prevention Strategies - p. 203 14. Safety of Psychotropic Medications During Pregnancy - p. 215 15. Treatment of Viral Infections During Pregnancy - p. 235 16. Drugs to Control Diabetes During Pregnancy - p. 257 17. The Use of Cardiotonic Drugs in Neonates - p. 273 18. Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia - p. 291 19. Pharmacologic Prevention and Treatment of Neonatal Brain Injury - p. 311 20. Drugs for the Prevention and Treatment of Sepsis in the Newborn - p. 327 21. Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome - p. 349 22. Balancing the Use of Medications While Maintaining Breastfeeding - p. 367 23. Principles of Pharmacokinetics in the Pregnant Woman and Fetus - p. 383 24. Challenges in Designing Clinical Trials to Test New Drugs in the Pregnant Woman and Fetus - p. 399
No hay muestra disponible
No hay ficha técnica disponible
In consultation with Consulting Editor, Dr. Lucky Jain, Drs. Jonathan M. Davis and Errol R. Norwitz have put together a state-of the-art issue of the Clinics in Perinatology devoted to Perinatal Pharmacology. Clinical review articles are specifically devoted to the following: Drugs for the prevention and treatment of preterm labor; Drugs for the prevention and treatment of hypertensive disorders of pregnancy; Drugs to promote neuroprotection; Medications that cause fetal anomalies and possible prevention strategies; Safety and efficacy of psychotropic medications during pregnancy; Treatment of viral infections during pregnancy (HIV, herpes, CMV, hepatitis C); Drugs to control diabetes during pregnancy; Cardiotonic drugs; Drugs to treat coagulation disorders in the newborn; Drugs for the prevention and treatment of bronchopulmonary dysplasia; Drugs for the prevention and treatment of neonatal brain injury; Drugs for the prevention and treatment of sepsis in the newborn; Analgesia, opioids and other drug use during pregnancy and Neonatal Abstinence Syndrome; Medications and breast feeding; Principles of pharmacokinetics in the pregnant woman and fetus; and Challenges in designing clinical trials to test new drugs in the pregnant woman and fetus. Readers will come away with the latest information on therapeutics as they seek to utilize evidence-based recommendations to improve patient outcomes.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. CME Accreditation Page - p. xi 7. Forthcoming Issues - p. xiii 8. Foreword - p. xv 9. Preface - p. xvii 10. Drugs for the Treatment and Prevention of Preterm Labor - p. 159 11. Treatment and Prevention of Hypertensive Disorders During Pregnancy - p. 173 12. Magnesium Sulfate and Novel Therapies to Promote Neuroprotection - p. 187 13. Medications that Cause Fetal Anomalies and Possible Prevention Strategies - p. 203 14. Safety of Psychotropic Medications During Pregnancy - p. 215 15. Treatment of Viral Infections During Pregnancy - p. 235 16. Drugs to Control Diabetes During Pregnancy - p. 257 17. The Use of Cardiotonic Drugs in Neonates - p. 273 18. Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia - p. 291 19. Pharmacologic Prevention and Treatment of Neonatal Brain Injury - p. 311 20. Drugs for the Prevention and Treatment of Sepsis in the Newborn - p. 327 21. Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome - p. 349 22. Balancing the Use of Medications While Maintaining Breastfeeding - p. 367 23. Principles of Pharmacokinetics in the Pregnant Woman and Fetus - p. 383 24. Challenges in Designing Clinical Trials to Test New Drugs in the Pregnant Woman and Fetus - p. 399
No hay muestra disponible
No hay ficha técnica disponible
